DNA Nanotechnology Market Size, Trends and Insights By Type (Structural, Dynamic), By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Twist Bioscience Corporation
- NanoInk Inc.
- Oxford Nanopore Technologies Ltd.
- Illumina Inc.
- Agilent Technologies Inc.
- Others
Reports Description
Global DNA Nanotechnology Market was valued at USD 4.9 Billion in 2022 and is expected to reach USD 29.2 Billion by 2032, at a CAGR of 18.5% during the forecast period 2023 – 2032.
Utilizing the special qualities of DNA molecules, the area of DNA nanotechnology designs and builds nanoscale components and devices for a range of uses, including the delivery of drugs, molecule sensing, and nanoelectronics.
DNA Nanotechnology Market: Growth Factors
Surge in demand for the effective and efficient drug delivery system
The market for DNA nanotechnology has expanded due in significant measure to the increase in demand for efficient and effective medication delivery methods. When it comes to medicine delivery, DNA nanotechnology has several benefits: precise targeting, controlled release, and fewer adverse effects.
Through the programming structure of DNA molecules, scientists may create complex nanostructures that can carry medications and transport them to particular human areas or cells.
Drugs can be released at the target location in a triggered manner by using DNA nanocarriers that are designed to react to certain stimulation, such as pH or enzyme activity. The need for new methods of drug delivery based on DNA nanotechnology is anticipated to rise in tandem with the growing need for targeted therapeutics and customized medicine, propelling future market expansion and investment in research and development.
For instance, DNA nanotechnology demonstrated tremendous potential in recent years for medication delivery and bioimaging applications. Due to its appealing advantages, DNA nanostructures have become a unique class of nucleic acid delivery devices for biological applications. These advantages include precise geometries, increased biostability, and spatial addressability.
Increasing investments from the government and private sector in the healthcare sector
Increasing government and private sector expenditures in healthcare are essential to propelling the DNA nanotechnology business forward. These investments support research and development initiatives, enabling improvements in DNA nanotechnology-based healthcare solutions.
With more funding, researchers may investigate novel uses for DNA nanotechnology, such as tailored drug delivery systems, early illness detection tools, and precision medicine approaches.
Furthermore, greater financing makes it easier to translate these breakthroughs from the lab to real-world clinical applications, eventually boosting patient outcomes and healthcare efficiency.
The coordinated efforts of government agencies, academic institutions, and private businesses create an atmosphere conducive to advancements in DNA nanotechnology, resulting in the creation of more effective and tailored healthcare options.
Overall, these investments do not only drive the development of the DNA nanotechnology market as well as contribute significantly to the advancement of healthcare technologies and services.
DNA Nanotechnology Market: Restraints
High capital investment requirement
High investment in capital requirements hinders the DNA nanotechnology sector by limiting entrance for smaller enterprises and startups. Sophisticated equipment, specialized materials, and professional individuals are required for DNA-based nanodevice research, development, and production, and need substantial financial resources.
This initial expenditure may dissuade future investors and limit the number of market participants, lowering competition and innovation. Furthermore, the high risk associated with such large expenditures may deter venture capitalists and other funding sources from backing DNA nanotechnology businesses.
As a result, promising research and prospective discoveries could remain underdeveloped or unavailable, stifling industry growth and delaying the translation of DNA nanotechnology advances into practice.
DNA Nanotechnology Market: Opportunities
Rising advancements in nanotechnology
Advances in nanotechnology, particularly in the field of DNA nanotechnology, are driving the market forward. As researchers get a better grasp of DNA’s properties and modification techniques, they will be able to create more sophisticated and precise nanostructures with a variety of functions.
These breakthroughs allow for the development of novel applications in medicine, such as tailored drug delivery systems and biological sensors for disease detection, as well as materials science and electronics. Various industries, including pharmaceuticals and electronics, are investing in DNA nanotechnology to improve their products and processes.
Furthermore, the cross-disciplinary character of DNA nanotechnology promotes collaboration among experts from other domains, resulting in increased innovation and commercial development.
Overall, the increasing tide of nanotechnological developments is leading the DNA nanotechnology market into exponential growth, with promising prospects for transformative applications across industries. For instance, according to the IUCN research, Micro/nano characteristics can be found in biological substances, cells, and living processes.
Artificial technologies in the micro- and nanoscale can connect with biological organisms nearby, providing new scientific insights along with whole new tools for illness detection and treatment.
DNA-NMs are of great interest because they combine DNA’s molecular recognition and programmability with the physical characteristics of organic or inorganic nanoparticles, resulting in promising applications in a variety of fields such as biosensing, drug delivery, materials science, and nanotechnology.
DNA Nanotechnology Market: Segmentation Analysis
The global DNA Nanotechnology market is segmented by type, application, end user and region. Based on type, the market is classified into structural and dynamic. Structural DNA nanotechnology dominated the market in 2022 with a market share of 65% and is expected to keep its dominance during the forecast period 2024-2032.
Structural DNA nanotechnology drives the DNA nanotechnology industry by allowing for precise oversight over the design and production of sophisticated nanoscale structures made from DNA molecules.
Researchers are using techniques such as DNA origami and DNA self-assembly to create complicated designs with unparalleled accuracy and flexibility. These structures are used as templates to create nanoscale devices with a variety of applications in health, biology, and materials research.
Structural DNA nanotechnology has various benefits, including programmability, scalability, and biocompatibility, making it a promising field for creating breakthrough solutions in targeted drug administration, biosensing, molecular computing, and nanoelectronics.
As research advances, the capacity to design increasingly complex DNA-based nanostructures will fuel innovation and growth in the DNA nanotechnology industry, opening the way for revolutionary technologies with major social impact.
Based on application, the market is classified into targeted drug delivery, smart pills, nanolithography, and others. The targeted drug delivery segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Targeted medicine delivery is a significant driver of the DNA nanotechnology industry because it allows therapeutic drugs to be precisely delivered to specific cells or tissues, reducing adverse effects and increasing treatment efficacy.
DNA nanotechnology allows for the design and production of complex nanotechnologies, such as DNA origami and DNA nanocarriers, which may encapsulate medications and deliver them to specific locations in the body. These nanocarriers may be programmed to respond to particular biological stimuli, such as pH or enzyme activity, enabling controlled medication release at the appropriate site.
Based on end users, the market is classified as biotechnology & pharmaceutical companies, academic & research institutions, and others. The biotechnology & pharmaceutical companies segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
These firms make significant investments in research and development to realize the potential of DNA nanotechnology for a variety of applications, such as targeted drug delivery systems, diagnostic tools, and personalized healthcare.
They use DNA’s programming and self-assembly capabilities to create unique nanoscale structures capable of effectively delivering medications to particular cells or tissues, increasing therapy efficacy while reducing negative effects.
Furthermore, pharmaceutical firms perceive DNA nanotechnology as a viable option for generating novel treatments and diagnostic tests, resulting in increasing investment and collaboration in the sector.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 4.9 Billion |
| Projected Market Size in 2032 | USD 29.2 Billion |
| Market Size in 2022 | USD 4.5 Billion |
| CAGR Growth Rate | 18.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
DNA Nanotechnology Market: Regional Analysis
By region, DNA Nanotechnology market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global DNA Nanotechnology market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
North America is a key driver of the DNA nanotechnology market due to its strong research infrastructure, major biotechnology investments, and dynamic network of academic institutions, laboratories for research, and biotech firms.
The region has prominent research facilities and universities that are pioneering advancements in DNA nanotechnology, drawing top talent and encouraging innovation. Furthermore, North America’s robust industrial sector and strategic partnerships between academics and business hasten the translation of research discoveries into commercial applications.
Furthermore, supporting government initiatives, good regulatory regulations, and significant financial opportunities drive expansion in this industry. As a result, North America is a critical hub for developing DNA nanotechnology, driving technical developments, and changing the worldwide landscape of this new sector.
DNA Nanotechnology Market: Recent Developments
- In March 2022, NuProbe planned to commercialize a DNA nanotech-based variant detection technology as a faster, less expensive diagnosis for cancer and infectious disorders.
- In November 2021, Genisphere LLC, the developer of the 3DNA® nanotechnology platform, received fund $400 million to enhance the research of Genisphere’s targeted drug delivery technology, to license the 3DNA® platform to pharmaceutical partners and complete preclinical studies.
- In April 2022, INOVIO and Coherus collaborated firm that focuses on creating and commercializing DNA therapeutics to help cure and protect individuals from HPV-related disorders, cancer, and infectious diseases to develop INO-3112 in combination with LOQTORZI™.
List of the prominent players in the DNA Nanotechnology Market:
- Twist Bioscience Corporation
- NanoInk Inc.
- Oxford Nanopore Technologies Ltd.
- Illumina Inc.
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Bruker Corporation
- New England Biolabs Inc.
- LGC Biosearch Technologies
- Codex DNA Inc.
- Evonetix Ltd.
- GenScript Biotech Corporation
- Synthego Corporation
- SPT Labtech
- Ginkgo Bioworks
- Eurofins Scientific SE
- Nanion Technologies GmbH
- Bioneer Corporation
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The DNA Nanotechnology Market is segmented as follows:
By Type
- Structural
- Dynamic
By Application
- Targeted Drug Delivery
- Smart Pills
- Nanolithography
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutions
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global DNA Nanotechnology Market, (2024 – 2033) (USD Billion)
- 2.2 Global DNA Nanotechnology Market: snapshot
- Chapter 3. Global DNA Nanotechnology Market – Industry Analysis
- 3.1 DNA Nanotechnology Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Surge in demand for an effective and efficient drug delivery system
- 3.2.2 Increasing investments from the government and private sector in the healthcare sector
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global DNA Nanotechnology Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global DNA Nanotechnology Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global DNA Nanotechnology Market – Type Analysis
- 5.1 Global DNA Nanotechnology Market Overview: By Type
- 5.1.1 Global DNA Nanotechnology Market Share, By Type, 2022 and – 2033
- 5.2 Structural
- 5.2.1 Global DNA Nanotechnology Market by Structural, 2024 – 2033 (USD Billion)
- 5.3 Dynamic
- 5.3.1 Global DNA Nanotechnology Market by Dynamic, 2024 – 2033 (USD Billion)
- 5.1 Global DNA Nanotechnology Market Overview: By Type
- Chapter 6. Global DNA Nanotechnology Market – Application Analysis
- 6.1 Global DNA Nanotechnology Market Overview: By Application
- 6.1.1 Global DNA Nanotechnology Market Share, By Application, 2022 and – 2033
- 6.2 Targeted Drug Delivery
- 6.2.1 Global DNA Nanotechnology Market by Targeted Drug Delivery, 2024 – 2033 (USD Billion)
- 6.3 Smart Pills
- 6.3.1 Global DNA Nanotechnology Market by Smart Pills, 2024 – 2033 (USD Billion)
- 6.4 Nanolithography
- 6.4.1 Global DNA Nanotechnology Market by Nanolithography, 2024 – 2033 (USD Billion)
- 6.5 Others
- 6.5.1 Global DNA Nanotechnology Market by Others, 2024 – 2033 (USD Billion)
- 6.1 Global DNA Nanotechnology Market Overview: By Application
- Chapter 7. Global DNA Nanotechnology Market – End User Analysis
- 7.1 Global DNA Nanotechnology Market Overview: By End User
- 7.1.1 Global DNA Nanotechnology Market Share, By End User, 2022 and – 2033
- 7.2 Biotechnology & Pharmaceutical Companies
- 7.2.1 Global DNA Nanotechnology Market by Biotechnology & Pharmaceutical Companies, 2024 – 2033 (USD Billion)
- 7.3 Academic & Research Institutions
- 7.3.1 Global DNA Nanotechnology Market by Academic & Research Institutions, 2024 – 2033 (USD Billion)
- 7.4 Others
- 7.4.1 Global DNA Nanotechnology Market by Others, 2024 – 2033 (USD Billion)
- 7.1 Global DNA Nanotechnology Market Overview: By End User
- Chapter 8. DNA Nanotechnology Market – Regional Analysis
- 8.1 Global DNA Nanotechnology Market Regional Overview
- 8.2 Global DNA Nanotechnology Market Share, by Region, 2022 & – 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America DNA Nanotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.4 North America DNA Nanotechnology Market, by Type, 2024 – 2033
- 8.4.1 North America DNA Nanotechnology Market, by Type, 2024 – 2033 (USD Billion)
- 8.5 North America DNA Nanotechnology Market, by Application, 2024 – 2033
- 8.5.1 North America DNA Nanotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.6 North America DNA Nanotechnology Market, by End User, 2024 – 2033
- 8.6.1 North America DNA Nanotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe DNA Nanotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.8 Europe DNA Nanotechnology Market, by Type, 2024 – 2033
- 8.8.1 Europe DNA Nanotechnology Market, by Type, 2024 – 2033 (USD Billion)
- 8.9 Europe DNA Nanotechnology Market, by Application, 2024 – 2033
- 8.9.1 Europe DNA Nanotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.10 Europe DNA Nanotechnology Market, by End User, 2024 – 2033
- 8.10.1 Europe DNA Nanotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific DNA Nanotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific DNA Nanotechnology Market, by Type, 2024 – 2033
- 8.12.1 Asia Pacific DNA Nanotechnology Market, by Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific DNA Nanotechnology Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific DNA Nanotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific DNA Nanotechnology Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific DNA Nanotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America DNA Nanotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America DNA Nanotechnology Market, by Type, 2024 – 2033
- 8.16.1 Latin America DNA Nanotechnology Market, by Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America DNA Nanotechnology Market, by Application, 2024 – 2033
- 8.17.1 Latin America DNA Nanotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.18 Latin America DNA Nanotechnology Market, by End User, 2024 – 2033
- 8.18.1 Latin America DNA Nanotechnology Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa DNA Nanotechnology Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa DNA Nanotechnology Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa DNA Nanotechnology Market, by Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa DNA Nanotechnology Market, by Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa DNA Nanotechnology Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa DNA Nanotechnology Market, by Application, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa DNA Nanotechnology Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa DNA Nanotechnology Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Twist Bioscience Corporation
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 NanoInk Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Oxford Nanopore Technologies Ltd.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Illumina Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Agilent Technologies Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Thermo Fisher Scientific Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Bio-Rad Laboratories Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Danaher Corporation
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Bruker Corporation
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 New England Biolabs Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 LGC Biosearch Technologies
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Codex DNA Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Evonetix Ltd.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 GenScript Biotech Corporation
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Synthego Corporation
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 SPT Labtech
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Ginkgo Bioworks
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Eurofins Scientific SE
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Nanion Technologies GmbH
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Bioneer Corporation
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Twist Bioscience Corporation
List Of Figures
Figures No 1 to 25
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Twist Bioscience Corporation
- NanoInk Inc.
- Oxford Nanopore Technologies Ltd.
- Illumina Inc.
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Bruker Corporation
- New England Biolabs Inc.
- LGC Biosearch Technologies
- Codex DNA Inc.
- Evonetix Ltd.
- GenScript Biotech Corporation
- Synthego Corporation
- SPT Labtech
- Ginkgo Bioworks
- Eurofins Scientific SE
- Nanion Technologies GmbH
- Bioneer Corporation
- Others
FAQs
The restraints of the DNA Nanotechnology market is high capital investment requirement.
The major driver for the DNA Nanotechnology market is surge in demand for the effective and efficient drug delivery system and increasing investments from the government and private sector in the healthcare sector.
The “Structural ” category dominated the market in 2022.
The key players in the market are Twist Bioscience Corporation, NanoInk Inc. , Oxford Nanopore Technologies Ltd., Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Bruker Corporation, New England Biolabs Inc., LGC Biosearch Technologies, Codex DNA Inc., Evonetix Ltd., GenScript Biotech Corporation, Synthego Corporation, SPT Labtech, Ginkgo Bioworks, Eurofins Scientific SE, Nanion Technologies GmbH, Bioneer Corporation, Others.
“North America” had the largest share in the DNA Nanotechnology Market.
The global market is projected to grow at a CAGR of 18.5% during the forecast period, 2023-2032.
The DNA Nanotechnology Market size was valued at USD 4.9 Billion in 2023.